Cannabinoids for Pain

same indica but almost harvest

GW Pharma Limited (United Kingdom) and Otsuka Pharmaceutical Co. Limited (Japan) have filed an¬†International Patent Application for specific “Cannabinoids for the Treatment of Neuropathic Pain”!

The English Abstract is as follows:

“The present invention relates to cannabinoids for use in the treatment of neuropathic pain. Preferably the cannabinoids are one or more phytocannabinoids of: cannabigerol (CBG), cannabichromene (CBC), cannabidivarin (CBDV) or tetrahydrocannabivarin (THCV). More preferably the phytocannabinoids are isolated and / or purified from cannabis plant extracts.”

This patent claims that it is a novel discovery, however, in the book “Cannabinoids and Terpenes: The Medicinal Benefits of Cannabis“, Ryder Management along with many other patients of medical cannabis, have known this for years.